The significance of the sequence of administration of topotecan and etoposide

Cancer Chemotherapy and Pharmacology

Volumn 39, Issue 1-2, 1996, Pages 109-112

  Bonner, James A ^a   Kozelsky, Timothy F ^a  

^a MAYO CLINIC   (United States)

Author keywords

Etoposide; Synergy; Topotecan

Indexed keywords

DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); ENZYME INHIBITOR; ETOPOSIDE; TOPOTECAN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL STRAIN V 79; CELL SURVIVAL; COLONY FORMATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENTIATION; HAMSTER; IN VITRO STUDY; LUNG CANCER; LUNG FIBROBLAST; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CELL SURVIVAL; CELLS, CULTURED; CRICETINAE; DNA TOPOISOMERASES, TYPE I; DRUG SYNERGISM; ENZYME INHIBITORS; ETOPOSIDE; FIBROBLASTS; LUNG; TOPOTECAN;

EID: 0029801803     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050545     Document Type: Article

References (17)

1. Abigerges D, Armand J-P, Chabot GG, et al (1994) Irinotecan (CPT-11) high-dose escalation using intensive high-dose loperamide to control diarrhea. J Natl Cancer Inst 86 (6):446-449
2. Ackland SP, Schilsky RL, Beckett MA, Weichselbaum RR (1988) Synergistic cytotoxicity and DNA strand break formation by bromodeoxyuridine and bleomycin in human tumor cells. Cancer Res 48:4244-4249
3. Anzai H, Frost P, Abbruzzese JL (1992) Synergistic cytotoxicity with 2'-deoxy-5-azacytidine and topotecan in vitro and in vivo. Cancer Res 52:2180-2185
4. Bertrand R, O'Conner PM, Kerrigan D, Pommier Y (1992) Sequential administration of camptothecin and etoposide circumvents the antagonistic cytotoxicity of simultaneous drug administration in slowly growing human colon carcinoma HT-29 cells. Eur J Cancer 28A (4/5):743-748
5. Bonner JA, Liengswangwong V (1994) Topoisomerase II-independent doxorubicin-induced cytotoxicity in an extremely doxorubicin-resistant cell line. Biochem Biophys Res Commun 198 (2):582-589
6. Chou TC, Talalay P (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22:27-55
7. D'Arpa P, Liu LF (1989) Topoisomerase-targeting antitumor drugs. Biochim Biophys Acta 989:163-177
8. Eckardt JR, Burris HA, Von Hoff DD, et al (1994) Measurement of tumor topoisomerase I and II levels during the sequential administration of topotecan and etoposide. J Clin Oncol 13:141
9. Hochster H, Liebes L, Speyer J, Sorich J, Taubes B, Oratz R, Wernz J, Chachoua A, Raphael B, Vinci RZ, et al (1994) Phase I trial of low-dose continuous topotecan infusion in patients with cancer: an active and well-tolerated regimen. J Clin Oncol 12 (3):553-559
10. Karato A, Sasaki Y, Shinkai T, Eguchi K, Tamura T, Ohe Y, Oshita F, Nishio M, Kunikane H, Arioka H, et al (1993) Phase I study of CPT-11 and etoposide in patients with refractory solid tumors. J Clin Oncol 11:2030-2035
11. Kaufmann SH (1991) Antagonism between camptothecin and topoisomerase II-directed chemotherapeutic ages in a human leukemia cell line. Cancer Res 51:1129-1136
12. Kim R, Hirabayashi N, Nishiyama M, Jinushi K, Toge T, Okada K (1992) Experimental studies on biochemical modulation targeting topoisomerase I and II in human tumor xenografts in nude mice. Int J Cancer 50:760-766
13. Pratt CB, Stewart C, Santana VM, Bowman L, Furman W, Ochs J, Marina N, Kuttesch JF, Heideman R, Sandlund JT, et al (1994) Phase I study of topotecan for pediatric patients with malignant solid tumors. J Clin Oncol 12 (3):539-543
14. Ratain MJ, Schilsky RL, Wojack BR, Simon T, Senekjian EK, Vogelzang NJ (1988) Hydroxyurea and etoposide: in vitro synergy and phase I clinical trials. J Natl Cancer Inst 80:1412-1416
15. Slichenmyer WJ, Rowinsky EK, Donehower RC, Kaufmann SH (1993) The current status of camptothecin analogues as antitumor agents. J Natl Cancer Inst 85 (4):271-291
16. Tanizawa A, Fujimorei A, Fujimorei Y (1994) Comparison of topoisomerase I inhibition, DNA damage, and cytotoxicity of camptothecin derivatives presently in clinical trials. J Natl Cancer Inst 86 (11):836-842
17. Tewey KM, Rowe TC, Yang L, Halligan BD, Liu LF (1984) Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science 226:466-468